

Eye drops used in managing glaucoma decrease eye pressure by helping the eye’s fluid to drain better andor decreasing the amount of fluid made by the eye.
The global Glaucoma Eye Drops market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Glaucoma Eye Drops is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Glaucoma Eye Drops is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Glaucoma Eye Drops is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Glaucoma Eye Drops include Novartis, Allergan, Mylan and Bausch + Lomb, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Glaucoma Eye Drops, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Glaucoma Eye Drops, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Glaucoma Eye Drops, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Glaucoma Eye Drops sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Glaucoma Eye Drops market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Glaucoma Eye Drops sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Mylan
Bausch + Lomb
Segment by Type
Prostaglandin Analogs
Beta Blockers
Alpha Agonists
Carbonic Anhydrase Inhibitors (CAIs)
Rho Khinase Inhibitors
Segment by Application
Hospital Pharmacies
Optical Shop
Online Stores
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Glaucoma Eye Drops in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Glaucoma Eye Drops manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glaucoma Eye Drops sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Glaucoma Eye Drops Product Introduction
1.2 Market by Type
1.2.1 Global Glaucoma Eye Drops Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Prostaglandin Analogs
1.2.3 Beta Blockers
1.2.4 Alpha Agonists
1.2.5 Carbonic Anhydrase Inhibitors (CAIs)
1.2.6 Rho Khinase Inhibitors
1.3 Market by Application
1.3.1 Global Glaucoma Eye Drops Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Optical Shop
1.3.4 Online Stores
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Glaucoma Eye Drops Sales Estimates and Forecasts 2019-2030
2.2 Global Glaucoma Eye Drops Revenue by Region
2.2.1 Global Glaucoma Eye Drops Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Glaucoma Eye Drops Revenue by Region (2019-2024)
2.2.3 Global Glaucoma Eye Drops Revenue by Region (2025-2030)
2.2.4 Global Glaucoma Eye Drops Revenue Market Share by Region (2019-2030)
2.3 Global Glaucoma Eye Drops Sales Estimates and Forecasts 2019-2030
2.4 Global Glaucoma Eye Drops Sales by Region
2.4.1 Global Glaucoma Eye Drops Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Glaucoma Eye Drops Sales by Region (2019-2024)
2.4.3 Global Glaucoma Eye Drops Sales by Region (2025-2030)
2.4.4 Global Glaucoma Eye Drops Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Glaucoma Eye Drops Sales by Manufacturers
3.1.1 Global Glaucoma Eye Drops Sales by Manufacturers (2019-2024)
3.1.2 Global Glaucoma Eye Drops Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Glaucoma Eye Drops in 2023
3.2 Global Glaucoma Eye Drops Revenue by Manufacturers
3.2.1 Global Glaucoma Eye Drops Revenue by Manufacturers (2019-2024)
3.2.2 Global Glaucoma Eye Drops Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Glaucoma Eye Drops Revenue in 2023
3.3 Global Key Players of Glaucoma Eye Drops, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Glaucoma Eye Drops Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Glaucoma Eye Drops Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Glaucoma Eye Drops, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Glaucoma Eye Drops, Product Offered and Application
3.8 Global Key Manufacturers of Glaucoma Eye Drops, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Glaucoma Eye Drops Sales by Type
4.1.1 Global Glaucoma Eye Drops Historical Sales by Type (2019-2024)
4.1.2 Global Glaucoma Eye Drops Forecasted Sales by Type (2025-2030)
4.1.3 Global Glaucoma Eye Drops Sales Market Share by Type (2019-2030)
4.2 Global Glaucoma Eye Drops Revenue by Type
4.2.1 Global Glaucoma Eye Drops Historical Revenue by Type (2019-2024)
4.2.2 Global Glaucoma Eye Drops Forecasted Revenue by Type (2025-2030)
4.2.3 Global Glaucoma Eye Drops Revenue Market Share by Type (2019-2030)
4.3 Global Glaucoma Eye Drops Price by Type
4.3.1 Global Glaucoma Eye Drops Price by Type (2019-2024)
4.3.2 Global Glaucoma Eye Drops Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Glaucoma Eye Drops Sales by Application
5.1.1 Global Glaucoma Eye Drops Historical Sales by Application (2019-2024)
5.1.2 Global Glaucoma Eye Drops Forecasted Sales by Application (2025-2030)
5.1.3 Global Glaucoma Eye Drops Sales Market Share by Application (2019-2030)
5.2 Global Glaucoma Eye Drops Revenue by Application
5.2.1 Global Glaucoma Eye Drops Historical Revenue by Application (2019-2024)
5.2.2 Global Glaucoma Eye Drops Forecasted Revenue by Application (2025-2030)
5.2.3 Global Glaucoma Eye Drops Revenue Market Share by Application (2019-2030)
5.3 Global Glaucoma Eye Drops Price by Application
5.3.1 Global Glaucoma Eye Drops Price by Application (2019-2024)
5.3.2 Global Glaucoma Eye Drops Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Glaucoma Eye Drops Market Size by Type
6.1.1 US & Canada Glaucoma Eye Drops Sales by Type (2019-2030)
6.1.2 US & Canada Glaucoma Eye Drops Revenue by Type (2019-2030)
6.2 US & Canada Glaucoma Eye Drops Market Size by Application
6.2.1 US & Canada Glaucoma Eye Drops Sales by Application (2019-2030)
6.2.2 US & Canada Glaucoma Eye Drops Revenue by Application (2019-2030)
6.3 US & Canada Glaucoma Eye Drops Market Size by Country
6.3.1 US & Canada Glaucoma Eye Drops Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Glaucoma Eye Drops Sales by Country (2019-2030)
6.3.3 US & Canada Glaucoma Eye Drops Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Glaucoma Eye Drops Market Size by Type
7.1.1 Europe Glaucoma Eye Drops Sales by Type (2019-2030)
7.1.2 Europe Glaucoma Eye Drops Revenue by Type (2019-2030)
7.2 Europe Glaucoma Eye Drops Market Size by Application
7.2.1 Europe Glaucoma Eye Drops Sales by Application (2019-2030)
7.2.2 Europe Glaucoma Eye Drops Revenue by Application (2019-2030)
7.3 Europe Glaucoma Eye Drops Market Size by Country
7.3.1 Europe Glaucoma Eye Drops Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Glaucoma Eye Drops Sales by Country (2019-2030)
7.3.3 Europe Glaucoma Eye Drops Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Glaucoma Eye Drops Market Size
8.1.1 China Glaucoma Eye Drops Sales (2019-2030)
8.1.2 China Glaucoma Eye Drops Revenue (2019-2030)
8.2 China Glaucoma Eye Drops Market Size by Application
8.2.1 China Glaucoma Eye Drops Sales by Application (2019-2030)
8.2.2 China Glaucoma Eye Drops Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Glaucoma Eye Drops Market Size by Type
9.1.1 Asia Glaucoma Eye Drops Sales by Type (2019-2030)
9.1.2 Asia Glaucoma Eye Drops Revenue by Type (2019-2030)
9.2 Asia Glaucoma Eye Drops Market Size by Application
9.2.1 Asia Glaucoma Eye Drops Sales by Application (2019-2030)
9.2.2 Asia Glaucoma Eye Drops Revenue by Application (2019-2030)
9.3 Asia Glaucoma Eye Drops Sales by Region
9.3.1 Asia Glaucoma Eye Drops Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Glaucoma Eye Drops Revenue by Region (2019-2030)
9.3.3 Asia Glaucoma Eye Drops Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Glaucoma Eye Drops Market Size by Type
10.1.1 Middle East, Africa and Latin America Glaucoma Eye Drops Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Glaucoma Eye Drops Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Glaucoma Eye Drops Market Size by Application
10.2.1 Middle East, Africa and Latin America Glaucoma Eye Drops Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Glaucoma Eye Drops Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Glaucoma Eye Drops Sales by Country
10.3.1 Middle East, Africa and Latin America Glaucoma Eye Drops Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Glaucoma Eye Drops Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Glaucoma Eye Drops Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Glaucoma Eye Drops Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Novartis Glaucoma Eye Drops Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Allergan
11.2.1 Allergan Company Information
11.2.2 Allergan Overview
11.2.3 Allergan Glaucoma Eye Drops Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Allergan Glaucoma Eye Drops Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Overview
11.3.3 Mylan Glaucoma Eye Drops Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Mylan Glaucoma Eye Drops Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mylan Recent Developments
11.4 Bausch + Lomb
11.4.1 Bausch + Lomb Company Information
11.4.2 Bausch + Lomb Overview
11.4.3 Bausch + Lomb Glaucoma Eye Drops Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Bausch + Lomb Glaucoma Eye Drops Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bausch + Lomb Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Glaucoma Eye Drops Industry Chain Analysis
12.2 Glaucoma Eye Drops Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Glaucoma Eye Drops Production Mode & Process
12.4 Glaucoma Eye Drops Sales and Marketing
12.4.1 Glaucoma Eye Drops Sales Channels
12.4.2 Glaucoma Eye Drops Distributors
12.5 Glaucoma Eye Drops Customers
13 Market Dynamics
13.1 Glaucoma Eye Drops Industry Trends
13.2 Glaucoma Eye Drops Market Drivers
13.3 Glaucoma Eye Drops Market Challenges
13.4 Glaucoma Eye Drops Market Restraints
14 Key Findings in The Global Glaucoma Eye Drops Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Novartis
Allergan
Mylan
Bausch + Lomb
Ìý
Ìý
*If Applicable.